Items where authors include "Brandi, M.L."

Article

Kamenicky, P. orcid.org/0000-0002-1994-4226, Briot, K. orcid.org/0000-0002-6238-2601, Brandi, M.L. orcid.org/0000-0002-8741-0592 et al. (14 more authors) (2023) Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open, 9 (1). e002676. ISSN 2056-5933

Bilezikian, J.P. orcid.org/0000-0002-1570-2617, Khan, A.A. orcid.org/0000-0003-3733-8956, Silverberg, S.J. orcid.org/0000-0002-1074-2679 et al. (11 more authors) (2022) Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. Journal of Bone and Mineral Research, 37 (11). pp. 2293-2314. ISSN 0884-0431

Fusaro, M., Re Sartò, G.V., Gallieni, M. et al. (32 more authors) (2022) Time for revival of bone biopsy with histomorphometric analysis in chronic kidney disease (CKD): moving from skepticism to pragmatism. Nutrients, 14 (9). 1742. ISSN 2072-6643

Briot, K., Portale, A.A., Brandi, M.L. et al. (27 more authors) (2021) Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension. RMD Open, 7 (3). e001714. ISSN 2056-5933

Javaid, M.K., Boyce, A., Appelman-Dijkstra, N. et al. (18 more authors) (2019) Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome : a consensus statement from the FD/MAS international consortium. Orphanet Journal of Rare Diseases, 14 (1). 139. ISSN 1750-1172

Lorentzon, M., Branco, J., Brandi, M.L. et al. (22 more authors) (2019) Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis. Advances in Therapy, 36 (10). pp. 2811-2824. ISSN 0741-238X

Cronin, O. orcid.org/0000-0002-1365-9942, Forsyth, L., Goodman, K. et al. (39 more authors) (2019) Zoledronate in the prevention of Paget's (ZiPP) : protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone. BMJ Open, 9 (9). e030689.

Habibullah, M., Porter, J.A., Kluger, N. et al. (6 more authors) (2018) Calcium-sensing receptor autoantibodies in patients with autoimmune polyendocrine syndrome type 1: epitopes, specificity, functional affinity, IgG subclass, and effects on receptor activity. Journal of Immunology, 201 (11). pp. 3175-3183. ISSN 0022-1767

Buckinx, F., Landi, F., Cesari, M. et al. (28 more authors) (2018) The Authors reply: "Dual energy X-ray absorptiometry: gold standard for muscle mass?". Journal of Cachexia, Sarcopenia and Muscle, 9 (4). pp. 788-790. ISSN 2190-6009

Buckinx, F., Landi, F., Cesari, M. et al. (28 more authors) (2018) Pitfalls in the measurement of muscle mass: a need for a reference standard. Journal of Cachexia, Sarcopenia and Muscle, 9 (2). pp. 269-278. ISSN 2190-5991

Kanis, J.A., Cooper, C., Rizzoli, R. et al. (16 more authors) (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporosis International, 28 (7). pp. 2023-2034. ISSN 0937-941X

Hadji, P., Aapro, M.S., Body, J-J. et al. (18 more authors) (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology, 7. pp. 1-12. ISSN 2212-1374

Khan, A.A., Hanley, D.A., Rizzoli, R. et al. (29 more authors) (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis International, 28 (1). pp. 1-19. ISSN 0937-941X

Beaudart, C. orcid.org/0000-0002-0827-5303, McCloskey, E., Bruyère, O. et al. (21 more authors) (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatrics, 16. 170. ISSN 1471-2318

Reginster, J.-Y., Cooper, C., Rizzoli, R. et al. (20 more authors) (2016) Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clinical and Experimental Research, 28 (1). pp. 47-58. ISSN 1594-0667

Estrada, K., Styrkarsdottir, U., Evangelou, E. et al. (178 more authors) (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics, 44 (5). pp. 491-501. ISSN 1061-4036